Peter Buttrick
Concepts (556)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardium | 53 | 2018 | 970 | 3.640 |
Why?
| Heart Ventricles | 18 | 2023 | 727 | 2.330 |
Why?
| Heart Failure | 21 | 2023 | 1968 | 2.160 |
Why?
| Cardiomegaly | 20 | 2013 | 168 | 1.960 |
Why?
| Myocardial Contraction | 22 | 2011 | 339 | 1.940 |
Why?
| Protein Kinase C | 19 | 2014 | 297 | 1.880 |
Why?
| Ventricular Dysfunction, Right | 7 | 2023 | 232 | 1.790 |
Why?
| Myocytes, Cardiac | 13 | 2022 | 472 | 1.630 |
Why?
| Troponin I | 10 | 2013 | 83 | 1.390 |
Why?
| Isoenzymes | 17 | 2002 | 297 | 1.120 |
Why?
| Heart | 21 | 2022 | 631 | 1.030 |
Why?
| Ventricular Function, Right | 6 | 2023 | 257 | 0.990 |
Why?
| Myosins | 18 | 2018 | 130 | 0.900 |
Why?
| Muscle Proteins | 4 | 2022 | 219 | 0.890 |
Why?
| Actin Cytoskeleton | 6 | 2011 | 100 | 0.820 |
Why?
| Phosphorylation | 19 | 2016 | 1634 | 0.820 |
Why?
| Heart-Assist Devices | 3 | 2012 | 485 | 0.800 |
Why?
| Cardiomyopathy, Dilated | 6 | 2018 | 344 | 0.740 |
Why?
| Hypertension, Pulmonary | 8 | 2023 | 1794 | 0.730 |
Why?
| Ventricular Remodeling | 8 | 2023 | 229 | 0.730 |
Why?
| Protein Kinase C-epsilon | 9 | 2007 | 31 | 0.720 |
Why?
| Myosin Light Chains | 4 | 2013 | 35 | 0.700 |
Why?
| Scientific Misconduct | 1 | 2019 | 10 | 0.690 |
Why?
| Carrier Proteins | 5 | 2022 | 726 | 0.680 |
Why?
| Physical Conditioning, Animal | 8 | 2006 | 204 | 0.650 |
Why?
| Sarcomeres | 7 | 2021 | 91 | 0.650 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 5 | 2011 | 140 | 0.640 |
Why?
| Rats | 48 | 2013 | 5394 | 0.630 |
Why?
| Stroke Volume | 8 | 2023 | 513 | 0.630 |
Why?
| Neprilysin | 1 | 2018 | 48 | 0.620 |
Why?
| Animals | 86 | 2023 | 33399 | 0.600 |
Why?
| Editorial Policies | 1 | 2017 | 46 | 0.560 |
Why?
| Calcium | 11 | 2011 | 1171 | 0.540 |
Why?
| Myocardial Infarction | 8 | 2013 | 968 | 0.540 |
Why?
| Cardiac Myosins | 2 | 2013 | 33 | 0.540 |
Why?
| Myocardial Ischemia | 4 | 2019 | 251 | 0.530 |
Why?
| Adrenergic beta-Agonists | 5 | 2002 | 132 | 0.510 |
Why?
| Gene Expression Regulation | 8 | 2019 | 2446 | 0.510 |
Why?
| Histone Deacetylases | 2 | 2013 | 198 | 0.490 |
Why?
| Periodicals as Topic | 1 | 2017 | 191 | 0.490 |
Why?
| Clinical Trials as Topic | 1 | 2019 | 968 | 0.490 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 6 | 2021 | 246 | 0.480 |
Why?
| Serine | 3 | 2013 | 138 | 0.480 |
Why?
| Ventricular Function, Left | 4 | 2011 | 468 | 0.470 |
Why?
| Valproic Acid | 1 | 2013 | 44 | 0.450 |
Why?
| Rats, Wistar | 15 | 2006 | 399 | 0.450 |
Why?
| Hydroxamic Acids | 1 | 2013 | 80 | 0.440 |
Why?
| Aortic Valve Stenosis | 2 | 2013 | 296 | 0.420 |
Why?
| Ventricular Dysfunction, Left | 5 | 2023 | 374 | 0.420 |
Why?
| Mitogen-Activated Protein Kinases | 3 | 2002 | 299 | 0.420 |
Why?
| Isoproterenol | 6 | 2004 | 125 | 0.410 |
Why?
| RNA, Messenger | 15 | 2017 | 2661 | 0.380 |
Why?
| Recovery of Function | 2 | 2011 | 604 | 0.370 |
Why?
| Induced Pluripotent Stem Cells | 3 | 2021 | 185 | 0.360 |
Why?
| Mice | 27 | 2022 | 15528 | 0.350 |
Why?
| Dobutamine | 5 | 2005 | 36 | 0.350 |
Why?
| Apoptosis | 4 | 2002 | 2484 | 0.340 |
Why?
| Gene Expression | 12 | 2017 | 1492 | 0.330 |
Why?
| Receptors, Adrenergic, beta | 3 | 2011 | 144 | 0.330 |
Why?
| Angiotensin Receptor Antagonists | 3 | 1997 | 84 | 0.320 |
Why?
| Phosphoserine | 2 | 2007 | 34 | 0.320 |
Why?
| Humans | 51 | 2023 | 119032 | 0.310 |
Why?
| Cattle | 6 | 2023 | 979 | 0.310 |
Why?
| Protein Processing, Post-Translational | 5 | 2016 | 408 | 0.310 |
Why?
| Adrenergic beta-Antagonists | 2 | 2017 | 301 | 0.310 |
Why?
| Catecholamines | 5 | 2022 | 100 | 0.310 |
Why?
| Muscle Strength | 1 | 2010 | 283 | 0.300 |
Why?
| Tissue and Organ Procurement | 1 | 2010 | 248 | 0.300 |
Why?
| Hypertrophy, Right Ventricular | 3 | 2023 | 146 | 0.300 |
Why?
| Phenotype | 2 | 2013 | 3004 | 0.300 |
Why?
| Disease Models, Animal | 10 | 2023 | 3730 | 0.300 |
Why?
| Pharmacogenetics | 1 | 2008 | 151 | 0.300 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 195 | 0.290 |
Why?
| Glycolysis | 2 | 2012 | 224 | 0.290 |
Why?
| Mitochondria, Heart | 1 | 2007 | 76 | 0.290 |
Why?
| Biophysics | 1 | 2007 | 73 | 0.290 |
Why?
| NAD | 1 | 2007 | 67 | 0.280 |
Why?
| Cytosol | 1 | 2007 | 221 | 0.280 |
Why?
| Hypoxia-Inducible Factor 1 | 2 | 2006 | 64 | 0.280 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 2006 | 74 | 0.280 |
Why?
| Mice, Transgenic | 13 | 2018 | 2025 | 0.280 |
Why?
| Transforming Growth Factor beta | 2 | 2020 | 462 | 0.270 |
Why?
| Fibroblasts | 4 | 2020 | 843 | 0.260 |
Why?
| Hypertension, Renovascular | 3 | 1994 | 16 | 0.260 |
Why?
| Hypertension | 5 | 2007 | 1203 | 0.260 |
Why?
| Models, Animal | 1 | 2007 | 363 | 0.260 |
Why?
| Polymorphism, Genetic | 1 | 2008 | 642 | 0.250 |
Why?
| MAP Kinase Signaling System | 1 | 2006 | 293 | 0.250 |
Why?
| Myosin Heavy Chains | 3 | 2004 | 192 | 0.250 |
Why?
| Calcineurin | 2 | 2002 | 95 | 0.250 |
Why?
| Renin-Angiotensin System | 2 | 1996 | 82 | 0.250 |
Why?
| Male | 37 | 2020 | 57818 | 0.250 |
Why?
| Models, Biological | 2 | 2021 | 1715 | 0.250 |
Why?
| Endothelium, Vascular | 3 | 2019 | 907 | 0.240 |
Why?
| Gene Transfer Techniques | 3 | 2000 | 154 | 0.230 |
Why?
| Angiotensin II | 2 | 2001 | 107 | 0.230 |
Why?
| GATA4 Transcription Factor | 2 | 2020 | 18 | 0.230 |
Why?
| Female | 47 | 2020 | 61588 | 0.220 |
Why?
| Cardiovascular Diseases | 3 | 2007 | 1802 | 0.220 |
Why?
| Chronic Disease | 2 | 2020 | 1637 | 0.220 |
Why?
| Thromboxane A2 | 2 | 2002 | 13 | 0.220 |
Why?
| Cardiac Output, Low | 1 | 2002 | 68 | 0.210 |
Why?
| Rats, Inbred Strains | 14 | 1992 | 394 | 0.200 |
Why?
| Genetic Therapy | 3 | 2000 | 267 | 0.200 |
Why?
| Proto-Oncogene Proteins | 2 | 2002 | 618 | 0.200 |
Why?
| Fatty Acids, Unsaturated | 1 | 2002 | 86 | 0.200 |
Why?
| Heart Diseases | 2 | 2019 | 341 | 0.200 |
Why?
| Calcium Signaling | 3 | 2011 | 219 | 0.200 |
Why?
| Cyclosporine | 1 | 2001 | 173 | 0.190 |
Why?
| Gene Expression Regulation, Developmental | 3 | 2021 | 815 | 0.190 |
Why?
| Alternative Splicing | 1 | 2022 | 193 | 0.190 |
Why?
| Diabetes Mellitus, Experimental | 2 | 2004 | 211 | 0.190 |
Why?
| Organ Size | 12 | 2001 | 460 | 0.190 |
Why?
| Biomedical Research | 1 | 2007 | 612 | 0.190 |
Why?
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2002 | 165 | 0.190 |
Why?
| Brachial Artery | 1 | 2002 | 181 | 0.190 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 982 | 0.190 |
Why?
| Adaptation, Physiological | 4 | 2012 | 502 | 0.190 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 59 | 0.190 |
Why?
| Hemodynamics | 8 | 2011 | 1004 | 0.180 |
Why?
| Signal Transduction | 9 | 2021 | 4713 | 0.180 |
Why?
| Tetrazoles | 2 | 1997 | 32 | 0.180 |
Why?
| Blood Pressure | 11 | 2012 | 1664 | 0.180 |
Why?
| RNA, Long Noncoding | 1 | 2022 | 161 | 0.180 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 119 | 0.180 |
Why?
| Animals, Newborn | 5 | 2011 | 806 | 0.180 |
Why?
| Phototherapy | 1 | 2019 | 25 | 0.180 |
Why?
| Cardiotonic Agents | 3 | 2005 | 127 | 0.180 |
Why?
| Cell Dedifferentiation | 1 | 2019 | 30 | 0.180 |
Why?
| Molecular Sequence Data | 8 | 2012 | 2873 | 0.180 |
Why?
| Heart Rate | 8 | 2007 | 729 | 0.170 |
Why?
| Lysosomal-Associated Membrane Protein 2 | 1 | 2018 | 24 | 0.170 |
Why?
| Autophagosomes | 1 | 2018 | 21 | 0.170 |
Why?
| Cells, Cultured | 13 | 2021 | 4081 | 0.170 |
Why?
| Glycogen Storage Disease Type IIb | 1 | 2018 | 20 | 0.170 |
Why?
| Cocaine | 2 | 1991 | 158 | 0.170 |
Why?
| Circadian Clocks | 1 | 2019 | 48 | 0.170 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2018 | 219 | 0.170 |
Why?
| Membrane Fusion | 1 | 2018 | 40 | 0.170 |
Why?
| Body Weight | 10 | 2001 | 934 | 0.170 |
Why?
| Imidazoles | 2 | 1997 | 232 | 0.160 |
Why?
| Cell Culture Techniques | 1 | 2021 | 356 | 0.160 |
Why?
| In Vitro Techniques | 8 | 2011 | 1096 | 0.160 |
Why?
| Amphiregulin | 1 | 2018 | 21 | 0.160 |
Why?
| Filamins | 1 | 2018 | 16 | 0.160 |
Why?
| Lysosomes | 1 | 2018 | 136 | 0.160 |
Why?
| Systole | 3 | 2005 | 168 | 0.160 |
Why?
| Adenosine Triphosphatases | 5 | 2005 | 158 | 0.160 |
Why?
| Receptors, Histamine H2 | 1 | 2017 | 10 | 0.160 |
Why?
| Aging | 5 | 2008 | 1677 | 0.150 |
Why?
| Actomyosin | 1 | 1997 | 10 | 0.150 |
Why?
| Myocardial Reperfusion Injury | 1 | 2018 | 105 | 0.150 |
Why?
| Activities of Daily Living | 1 | 2020 | 355 | 0.150 |
Why?
| Physical Exertion | 3 | 1988 | 222 | 0.150 |
Why?
| Mice, Inbred C57BL | 8 | 2020 | 4914 | 0.150 |
Why?
| Period Circadian Proteins | 2 | 2019 | 22 | 0.150 |
Why?
| Coronary Circulation | 4 | 2004 | 121 | 0.150 |
Why?
| Protein Kinase C beta | 6 | 2008 | 26 | 0.150 |
Why?
| Hypoxia | 4 | 2023 | 963 | 0.150 |
Why?
| Angiotensin I | 1 | 1996 | 4 | 0.150 |
Why?
| Patient Participation | 1 | 2020 | 369 | 0.150 |
Why?
| Myofibrils | 2 | 2021 | 50 | 0.140 |
Why?
| Sex Characteristics | 3 | 2006 | 671 | 0.140 |
Why?
| Enzyme Inhibitors | 5 | 2002 | 829 | 0.140 |
Why?
| Middle Aged | 11 | 2020 | 27627 | 0.140 |
Why?
| Cellular Reprogramming Techniques | 1 | 2015 | 12 | 0.130 |
Why?
| Amino Acid Substitution | 2 | 2007 | 276 | 0.130 |
Why?
| Coronary Artery Disease | 1 | 2002 | 648 | 0.130 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 1996 | 193 | 0.130 |
Why?
| Ultrasonography | 2 | 2012 | 716 | 0.130 |
Why?
| Time Factors | 8 | 2009 | 6414 | 0.130 |
Why?
| rho-Associated Kinases | 1 | 2015 | 84 | 0.130 |
Why?
| Heart Transplantation | 4 | 2011 | 672 | 0.130 |
Why?
| Cellular Reprogramming | 1 | 2015 | 85 | 0.130 |
Why?
| Transcription, Genetic | 3 | 2019 | 1323 | 0.120 |
Why?
| Coronary Vessels | 2 | 1987 | 233 | 0.120 |
Why?
| Atrial Natriuretic Factor | 2 | 2007 | 59 | 0.120 |
Why?
| Tetracycline | 1 | 1994 | 13 | 0.120 |
Why?
| Blotting, Western | 2 | 2015 | 1195 | 0.120 |
Why?
| Echocardiography | 2 | 2009 | 556 | 0.120 |
Why?
| Interleukin-18 | 1 | 2016 | 229 | 0.120 |
Why?
| Amino Acid Sequence | 4 | 2012 | 2073 | 0.120 |
Why?
| Renin | 1 | 1993 | 35 | 0.120 |
Why?
| Cell Differentiation | 1 | 2021 | 1753 | 0.120 |
Why?
| Cardiac Output | 3 | 2012 | 147 | 0.120 |
Why?
| Transfection | 3 | 1993 | 890 | 0.110 |
Why?
| Protein Phosphatase 1 | 1 | 2013 | 32 | 0.110 |
Why?
| Protein Phosphatase 2 | 1 | 2013 | 35 | 0.110 |
Why?
| Sodium, Dietary | 1 | 1993 | 43 | 0.110 |
Why?
| Immunohistochemistry | 4 | 2018 | 1691 | 0.110 |
Why?
| Antihypertensive Agents | 1 | 1996 | 438 | 0.110 |
Why?
| Substance-Related Disorders | 2 | 1991 | 971 | 0.110 |
Why?
| Antibodies | 2 | 2013 | 392 | 0.110 |
Why?
| Cell Line | 6 | 2021 | 2707 | 0.110 |
Why?
| Protein Disulfide-Isomerases | 1 | 2012 | 10 | 0.110 |
Why?
| Contractile Proteins | 5 | 1996 | 17 | 0.110 |
Why?
| Muscle Fibers, Skeletal | 2 | 2005 | 192 | 0.110 |
Why?
| Receptor, Adenosine A2B | 1 | 2012 | 32 | 0.110 |
Why?
| Ventricular Function | 2 | 1991 | 60 | 0.100 |
Why?
| Practice Patterns, Physicians' | 1 | 2020 | 1200 | 0.100 |
Why?
| Aorta | 2 | 2007 | 367 | 0.100 |
Why?
| In Situ Nick-End Labeling | 2 | 2002 | 124 | 0.100 |
Why?
| Disease Progression | 3 | 2009 | 2490 | 0.100 |
Why?
| Ventricular Pressure | 1 | 2011 | 41 | 0.100 |
Why?
| Excitation Contraction Coupling | 1 | 2011 | 18 | 0.100 |
Why?
| Enzyme Activation | 3 | 2002 | 828 | 0.100 |
Why?
| Natriuretic Peptides | 1 | 2011 | 8 | 0.100 |
Why?
| Hyperbaric Oxygenation | 1 | 2011 | 39 | 0.100 |
Why?
| Ventricular Fibrillation | 1 | 1991 | 51 | 0.100 |
Why?
| Desmin | 1 | 2010 | 31 | 0.100 |
Why?
| Neurotransmitter Agents | 1 | 2011 | 76 | 0.100 |
Why?
| Epoprostenol | 3 | 1986 | 132 | 0.090 |
Why?
| Chest Pain | 1 | 1990 | 84 | 0.090 |
Why?
| Peptide Fragments | 2 | 2007 | 702 | 0.090 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2010 | 76 | 0.090 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 106 | 0.090 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2012 | 200 | 0.090 |
Why?
| Promoter Regions, Genetic | 6 | 1994 | 1158 | 0.090 |
Why?
| Cyclic AMP | 3 | 2008 | 242 | 0.090 |
Why?
| Extracellular Matrix Proteins | 1 | 2011 | 133 | 0.090 |
Why?
| Cardiovascular Physiological Phenomena | 2 | 2006 | 41 | 0.090 |
Why?
| Rats, Sprague-Dawley | 5 | 2012 | 2478 | 0.090 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2002 | 420 | 0.090 |
Why?
| Energy Metabolism | 3 | 2007 | 767 | 0.090 |
Why?
| Adult | 11 | 2020 | 31525 | 0.090 |
Why?
| Sex Factors | 2 | 2013 | 1781 | 0.090 |
Why?
| Mice, Knockout | 3 | 2022 | 2680 | 0.090 |
Why?
| Blotting, Northern | 2 | 2001 | 194 | 0.090 |
Why?
| Prosthesis Design | 1 | 2011 | 285 | 0.090 |
Why?
| Biopsy | 1 | 2013 | 1079 | 0.090 |
Why?
| Platelet Aggregation | 3 | 1986 | 97 | 0.080 |
Why?
| Muscle, Smooth, Vascular | 1 | 2012 | 457 | 0.080 |
Why?
| MicroRNAs | 2 | 2015 | 637 | 0.080 |
Why?
| Mitochondria | 1 | 2014 | 786 | 0.080 |
Why?
| Toxicogenetics | 1 | 2008 | 1 | 0.080 |
Why?
| Digoxin | 1 | 2008 | 27 | 0.080 |
Why?
| Cell Hypoxia | 2 | 2019 | 220 | 0.080 |
Why?
| Biomarkers, Pharmacological | 1 | 2008 | 26 | 0.080 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2010 | 490 | 0.080 |
Why?
| Mutation | 2 | 2018 | 3457 | 0.080 |
Why?
| Magnetic Resonance Spectroscopy | 3 | 2007 | 508 | 0.080 |
Why?
| Arrhythmias, Cardiac | 2 | 2022 | 277 | 0.080 |
Why?
| Tandem Mass Spectrometry | 1 | 2010 | 421 | 0.080 |
Why?
| RNA | 2 | 2006 | 833 | 0.080 |
Why?
| Embryo, Mammalian | 2 | 2020 | 220 | 0.080 |
Why?
| Gene Expression Regulation, Enzymologic | 4 | 2002 | 290 | 0.080 |
Why?
| Consensus Sequence | 1 | 2007 | 70 | 0.080 |
Why?
| Aged | 8 | 2020 | 19661 | 0.070 |
Why?
| Protein Conformation | 1 | 2010 | 848 | 0.070 |
Why?
| Ligation | 1 | 2007 | 82 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 2 | 2001 | 1947 | 0.070 |
Why?
| Biophysical Phenomena | 1 | 2007 | 64 | 0.070 |
Why?
| Oxidation-Reduction | 2 | 2007 | 940 | 0.070 |
Why?
| Clinical Medicine | 1 | 2007 | 20 | 0.070 |
Why?
| Heat Shock Transcription Factors | 1 | 2006 | 17 | 0.070 |
Why?
| Carnitine O-Palmitoyltransferase | 1 | 2007 | 47 | 0.070 |
Why?
| Base Sequence | 5 | 1994 | 2160 | 0.070 |
Why?
| Pregnancy, Animal | 1 | 1987 | 57 | 0.070 |
Why?
| Thyroid Hormones | 3 | 1993 | 55 | 0.070 |
Why?
| National Institutes of Health (U.S.) | 1 | 2007 | 115 | 0.070 |
Why?
| Retrospective Studies | 3 | 2012 | 12990 | 0.070 |
Why?
| Chloramphenicol O-Acetyltransferase | 4 | 1994 | 37 | 0.070 |
Why?
| Nitroimidazoles | 1 | 2006 | 6 | 0.070 |
Why?
| Butyrates | 1 | 2007 | 54 | 0.070 |
Why?
| Receptors, Corticotropin-Releasing Hormone | 1 | 2006 | 33 | 0.070 |
Why?
| DNA-Binding Proteins | 2 | 2006 | 1346 | 0.070 |
Why?
| Sequence Analysis, RNA | 2 | 2021 | 410 | 0.070 |
Why?
| Heat-Shock Proteins | 1 | 2006 | 129 | 0.070 |
Why?
| Heart Atria | 1 | 1986 | 112 | 0.070 |
Why?
| Corticotropin-Releasing Hormone | 1 | 2006 | 77 | 0.070 |
Why?
| Longitudinal Studies | 1 | 2012 | 2513 | 0.070 |
Why?
| Case-Control Studies | 1 | 2013 | 3173 | 0.070 |
Why?
| Swimming | 5 | 1990 | 46 | 0.070 |
Why?
| Age Factors | 3 | 2008 | 2995 | 0.070 |
Why?
| Transcription Factors | 2 | 2006 | 1570 | 0.070 |
Why?
| Mitochondrial Proteins | 1 | 2007 | 226 | 0.060 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 332 | 0.060 |
Why?
| Cloning, Molecular | 3 | 1997 | 546 | 0.060 |
Why?
| Phenylephrine | 2 | 2021 | 85 | 0.060 |
Why?
| Animals, Genetically Modified | 1 | 2005 | 225 | 0.060 |
Why?
| Enzyme Induction | 1 | 2004 | 94 | 0.060 |
Why?
| Osteopontin | 1 | 2004 | 39 | 0.060 |
Why?
| Cell Proliferation | 1 | 2012 | 2275 | 0.060 |
Why?
| Ventricular Myosins | 1 | 2004 | 33 | 0.060 |
Why?
| Sialoglycoproteins | 1 | 2004 | 162 | 0.060 |
Why?
| Kinetics | 3 | 2011 | 1625 | 0.060 |
Why?
| Drug Resistance | 1 | 2004 | 167 | 0.060 |
Why?
| Anticoagulants | 1 | 2008 | 559 | 0.060 |
Why?
| Exercise Therapy | 1 | 1987 | 357 | 0.060 |
Why?
| Mutagenesis | 1 | 2004 | 176 | 0.060 |
Why?
| Severity of Illness Index | 1 | 2011 | 2674 | 0.060 |
Why?
| Rats, Inbred F344 | 4 | 1997 | 245 | 0.060 |
Why?
| Recombinant Fusion Proteins | 2 | 2004 | 653 | 0.060 |
Why?
| Cytokines | 1 | 2011 | 1900 | 0.060 |
Why?
| Calcium-Transporting ATPases | 3 | 1993 | 35 | 0.060 |
Why?
| Up-Regulation | 2 | 2007 | 872 | 0.060 |
Why?
| Receptors, Adrenergic, alpha | 1 | 2002 | 32 | 0.050 |
Why?
| Massachusetts | 1 | 2022 | 141 | 0.050 |
Why?
| United States | 3 | 2022 | 12557 | 0.050 |
Why?
| RNA Splicing Factors | 1 | 2022 | 50 | 0.050 |
Why?
| Chromones | 1 | 2002 | 37 | 0.050 |
Why?
| Mechanotransduction, Cellular | 1 | 2023 | 101 | 0.050 |
Why?
| Pulsatile Flow | 1 | 2002 | 54 | 0.050 |
Why?
| GTP-Binding Proteins | 1 | 2002 | 147 | 0.050 |
Why?
| Androstadienes | 1 | 2002 | 95 | 0.050 |
Why?
| Hypertrophy | 1 | 2001 | 121 | 0.050 |
Why?
| Muscles | 3 | 1994 | 333 | 0.050 |
Why?
| Flavonoids | 1 | 2001 | 71 | 0.050 |
Why?
| Lac Operon | 1 | 2001 | 47 | 0.050 |
Why?
| beta-Galactosidase | 1 | 2001 | 65 | 0.050 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2022 | 311 | 0.050 |
Why?
| Morpholines | 1 | 2002 | 106 | 0.050 |
Why?
| Protein Isoforms | 1 | 2022 | 345 | 0.050 |
Why?
| Calcium Channels, L-Type | 1 | 2002 | 110 | 0.050 |
Why?
| American Heart Association | 1 | 2022 | 270 | 0.050 |
Why?
| Substrate Specificity | 1 | 2002 | 371 | 0.050 |
Why?
| Immunoblotting | 1 | 2001 | 307 | 0.050 |
Why?
| Sarcoplasmic Reticulum | 2 | 1993 | 43 | 0.050 |
Why?
| Culture Media | 1 | 2021 | 163 | 0.050 |
Why?
| Outpatients | 1 | 2023 | 325 | 0.050 |
Why?
| Collagen | 2 | 2016 | 433 | 0.050 |
Why?
| Health Services Misuse | 1 | 2020 | 36 | 0.050 |
Why?
| Cardiac Pacing, Artificial | 3 | 1998 | 85 | 0.050 |
Why?
| Protein Transport | 1 | 2001 | 412 | 0.050 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2018 | 2062 | 0.040 |
Why?
| Carotid Arteries | 1 | 2001 | 184 | 0.040 |
Why?
| Reactive Oxygen Species | 1 | 2002 | 576 | 0.040 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 404 | 0.040 |
Why?
| MAP Kinase Kinase Kinase 1 | 1 | 1999 | 14 | 0.040 |
Why?
| Biomechanical Phenomena | 2 | 1996 | 683 | 0.040 |
Why?
| Qa-SNARE Proteins | 1 | 2018 | 14 | 0.040 |
Why?
| Immediate-Early Proteins | 1 | 1999 | 55 | 0.040 |
Why?
| Organ Culture Techniques | 2 | 2007 | 149 | 0.040 |
Why?
| R-SNARE Proteins | 1 | 2018 | 19 | 0.040 |
Why?
| Action Potentials | 2 | 2015 | 420 | 0.040 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2018 | 48 | 0.040 |
Why?
| Autophagy-Related Proteins | 1 | 2018 | 46 | 0.040 |
Why?
| Gene Knockout Techniques | 1 | 2018 | 105 | 0.040 |
Why?
| Tachycardia | 1 | 1998 | 48 | 0.040 |
Why?
| Blood Platelets | 3 | 1986 | 369 | 0.040 |
Why?
| Protein-Tyrosine Kinases | 1 | 2002 | 407 | 0.040 |
Why?
| Hypertension, Renal | 2 | 1989 | 28 | 0.040 |
Why?
| Cell Survival | 1 | 2001 | 1047 | 0.040 |
Why?
| Protein Biosynthesis | 2 | 1997 | 397 | 0.040 |
Why?
| Streptozocin | 1 | 1997 | 23 | 0.040 |
Why?
| Hypertrophy, Left Ventricular | 1 | 1998 | 107 | 0.040 |
Why?
| Research Design | 2 | 2022 | 969 | 0.040 |
Why?
| Fatty Acids | 1 | 2021 | 407 | 0.040 |
Why?
| Prazosin | 1 | 1997 | 22 | 0.040 |
Why?
| Electrocardiography | 2 | 1991 | 556 | 0.040 |
Why?
| Microarray Analysis | 1 | 2018 | 124 | 0.040 |
Why?
| Adrenergic alpha-Agonists | 1 | 1997 | 31 | 0.040 |
Why?
| Death, Sudden | 1 | 1997 | 33 | 0.040 |
Why?
| Pharmacogenomic Variants | 1 | 2017 | 35 | 0.040 |
Why?
| Endothelial Cells | 1 | 2023 | 732 | 0.040 |
Why?
| Adenosine Triphosphate | 3 | 2011 | 439 | 0.040 |
Why?
| Biomarkers | 2 | 2013 | 3590 | 0.040 |
Why?
| Epinephrine | 3 | 1988 | 167 | 0.040 |
Why?
| Threonine | 1 | 1997 | 45 | 0.040 |
Why?
| Regional Blood Flow | 2 | 2012 | 418 | 0.040 |
Why?
| Diastole | 2 | 1988 | 145 | 0.040 |
Why?
| Integrases | 1 | 2018 | 123 | 0.040 |
Why?
| Proteomics | 1 | 2023 | 876 | 0.040 |
Why?
| Europe | 1 | 2018 | 356 | 0.040 |
Why?
| Alanine | 1 | 1997 | 102 | 0.040 |
Why?
| Treatment Outcome | 1 | 2011 | 9346 | 0.040 |
Why?
| DNA Mutational Analysis | 1 | 2018 | 381 | 0.040 |
Why?
| DNA Methylation | 1 | 2020 | 503 | 0.040 |
Why?
| Cell Adhesion | 1 | 2018 | 443 | 0.040 |
Why?
| Point Mutation | 1 | 1997 | 228 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 1 | 1997 | 364 | 0.030 |
Why?
| Dogs | 1 | 1997 | 371 | 0.030 |
Why?
| Peptides | 1 | 2001 | 879 | 0.030 |
Why?
| Regulatory Sequences, Nucleic Acid | 2 | 1993 | 80 | 0.030 |
Why?
| Physician-Patient Relations | 1 | 2020 | 489 | 0.030 |
Why?
| Chemokine CXCL12 | 1 | 2016 | 80 | 0.030 |
Why?
| Histones | 1 | 2020 | 552 | 0.030 |
Why?
| MEF2 Transcription Factors | 1 | 2015 | 57 | 0.030 |
Why?
| RNA, Small Interfering | 1 | 2018 | 564 | 0.030 |
Why?
| Creatine Kinase | 2 | 1997 | 75 | 0.030 |
Why?
| Chromatin Immunoprecipitation | 1 | 2015 | 135 | 0.030 |
Why?
| Biological Transport | 1 | 1996 | 382 | 0.030 |
Why?
| Phosphofructokinase-1 | 1 | 2014 | 7 | 0.030 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 160 | 0.030 |
Why?
| T-Box Domain Proteins | 1 | 2015 | 95 | 0.030 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2020 | 1244 | 0.030 |
Why?
| Oligonucleotide Probes | 1 | 1994 | 53 | 0.030 |
Why?
| Glucose Transporter Type 4 | 1 | 2014 | 38 | 0.030 |
Why?
| Luciferases | 2 | 1992 | 143 | 0.030 |
Why?
| Electron Transport Complex I | 1 | 2014 | 36 | 0.030 |
Why?
| Antibody Specificity | 2 | 2013 | 184 | 0.030 |
Why?
| Oxygen Consumption | 3 | 1997 | 586 | 0.030 |
Why?
| Troponin | 1 | 1994 | 47 | 0.030 |
Why?
| Succinate Dehydrogenase | 1 | 1994 | 44 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 333 | 0.030 |
Why?
| Cytochalasin B | 1 | 1974 | 17 | 0.030 |
Why?
| Proportional Hazards Models | 1 | 2017 | 1125 | 0.030 |
Why?
| Binding Sites, Antibody | 1 | 1974 | 38 | 0.030 |
Why?
| Connexin 43 | 1 | 1994 | 23 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2021 | 1597 | 0.030 |
Why?
| Adenoviridae | 1 | 1994 | 191 | 0.030 |
Why?
| DNA Copy Number Variations | 1 | 2014 | 167 | 0.030 |
Why?
| Thyroxine | 1 | 1994 | 63 | 0.030 |
Why?
| Norepinephrine | 3 | 1992 | 212 | 0.030 |
Why?
| Recombinant Proteins | 1 | 1997 | 1308 | 0.030 |
Why?
| Fibrosis | 1 | 2015 | 483 | 0.030 |
Why?
| Cytomegalovirus | 1 | 1993 | 144 | 0.030 |
Why?
| Quality Improvement | 1 | 2020 | 963 | 0.030 |
Why?
| Erythrocytes | 2 | 1977 | 641 | 0.030 |
Why?
| Immunodominant Epitopes | 1 | 2012 | 27 | 0.030 |
Why?
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2012 | 34 | 0.030 |
Why?
| Avian Sarcoma Viruses | 1 | 1992 | 4 | 0.030 |
Why?
| Transcriptional Activation | 1 | 1994 | 349 | 0.030 |
Why?
| Protein Array Analysis | 1 | 2012 | 63 | 0.030 |
Why?
| Genes, Viral | 1 | 1992 | 93 | 0.030 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2014 | 527 | 0.030 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2012 | 139 | 0.030 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2005 | 2179 | 0.030 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 1992 | 103 | 0.030 |
Why?
| Rabbits | 3 | 1993 | 780 | 0.030 |
Why?
| Perfusion | 2 | 1997 | 153 | 0.030 |
Why?
| Cardioplegic Solutions | 1 | 2011 | 6 | 0.030 |
Why?
| src-Family Kinases | 1 | 2012 | 90 | 0.030 |
Why?
| Phosphorus Radioisotopes | 1 | 2011 | 29 | 0.030 |
Why?
| Buffers | 1 | 2011 | 56 | 0.020 |
Why?
| Benzamides | 1 | 2012 | 176 | 0.020 |
Why?
| Swine | 1 | 2013 | 731 | 0.020 |
Why?
| Calcium Channel Blockers | 1 | 1991 | 117 | 0.020 |
Why?
| Antigen Presentation | 1 | 2012 | 194 | 0.020 |
Why?
| New York City | 1 | 1990 | 75 | 0.020 |
Why?
| Histocompatibility Antigens Class I | 1 | 2012 | 177 | 0.020 |
Why?
| Muscle, Skeletal | 2 | 1997 | 1523 | 0.020 |
Why?
| Education, Medical, Continuing | 1 | 1991 | 125 | 0.020 |
Why?
| Women's Health | 1 | 1992 | 274 | 0.020 |
Why?
| Endoplasmic Reticulum | 1 | 2012 | 241 | 0.020 |
Why?
| Growth Hormone | 1 | 1990 | 108 | 0.020 |
Why?
| T-Lymphocytes | 2 | 1994 | 1774 | 0.020 |
Why?
| Gonadal Steroid Hormones | 1 | 1990 | 122 | 0.020 |
Why?
| Pyrimidines | 1 | 2012 | 382 | 0.020 |
Why?
| Genes | 1 | 1989 | 231 | 0.020 |
Why?
| Genetic Predisposition to Disease | 1 | 2017 | 2275 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2013 | 1868 | 0.020 |
Why?
| Phosphocreatine | 2 | 1999 | 37 | 0.020 |
Why?
| Pyridines | 1 | 2012 | 440 | 0.020 |
Why?
| Injections, Subcutaneous | 1 | 1988 | 139 | 0.020 |
Why?
| Cell Size | 1 | 2008 | 86 | 0.020 |
Why?
| Risk Factors | 2 | 1991 | 9003 | 0.020 |
Why?
| Citric Acid Cycle | 1 | 2007 | 45 | 0.020 |
Why?
| Palmitic Acid | 1 | 2007 | 38 | 0.020 |
Why?
| Heart Function Tests | 1 | 2007 | 61 | 0.020 |
Why?
| DNA | 2 | 1991 | 1388 | 0.020 |
Why?
| Mitral Valve Stenosis | 1 | 1986 | 21 | 0.020 |
Why?
| Peptide Hormones | 1 | 2006 | 8 | 0.020 |
Why?
| Prospective Studies | 1 | 2018 | 6477 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2017 | 6562 | 0.020 |
Why?
| Mitral Valve Insufficiency | 1 | 1986 | 62 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2013 | 2874 | 0.020 |
Why?
| Stress, Mechanical | 1 | 2007 | 443 | 0.020 |
Why?
| Phentolamine | 1 | 1985 | 17 | 0.020 |
Why?
| Antibodies, Monoclonal | 1 | 2012 | 1285 | 0.020 |
Why?
| Adenosine Diphosphate | 1 | 1985 | 88 | 0.020 |
Why?
| Actins | 1 | 1987 | 404 | 0.020 |
Why?
| Cardiovascular System | 1 | 2006 | 127 | 0.020 |
Why?
| Vascular Resistance | 1 | 1986 | 356 | 0.020 |
Why?
| Rats, Inbred BN | 1 | 2004 | 53 | 0.020 |
Why?
| Rats, Inbred Lew | 1 | 2004 | 87 | 0.020 |
Why?
| Homeostasis | 1 | 2008 | 594 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 2 | 1999 | 536 | 0.010 |
Why?
| Algorithms | 1 | 2011 | 1543 | 0.010 |
Why?
| Prognosis | 1 | 1991 | 3443 | 0.010 |
Why?
| Motor Activity | 1 | 1988 | 666 | 0.010 |
Why?
| Phenanthridines | 1 | 2002 | 6 | 0.010 |
Why?
| Benzophenanthridines | 1 | 2002 | 10 | 0.010 |
Why?
| Alkaloids | 1 | 2002 | 23 | 0.010 |
Why?
| Papillary Muscles | 1 | 2002 | 13 | 0.010 |
Why?
| Mesylates | 1 | 2002 | 8 | 0.010 |
Why?
| Aspirin | 1 | 1985 | 334 | 0.010 |
Why?
| Detergents | 1 | 2002 | 44 | 0.010 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2002 | 155 | 0.010 |
Why?
| Second Messenger Systems | 1 | 2002 | 31 | 0.010 |
Why?
| Glucose | 1 | 2007 | 954 | 0.010 |
Why?
| Glucocorticoids | 1 | 2006 | 547 | 0.010 |
Why?
| Exercise | 1 | 1992 | 1657 | 0.010 |
Why?
| Membrane Potentials | 1 | 2002 | 253 | 0.010 |
Why?
| Fetus | 2 | 1997 | 690 | 0.010 |
Why?
| Pyrroles | 1 | 2002 | 191 | 0.010 |
Why?
| Tamoxifen | 1 | 1981 | 198 | 0.010 |
Why?
| Phosphates | 1 | 2001 | 168 | 0.010 |
Why?
| Calcium-Binding Proteins | 1 | 2001 | 217 | 0.010 |
Why?
| Proto-Oncogene Proteins c-raf | 1 | 1999 | 46 | 0.010 |
Why?
| Early Growth Response Protein 1 | 1 | 1999 | 32 | 0.010 |
Why?
| Deoxyuracil Nucleotides | 1 | 1998 | 2 | 0.010 |
Why?
| DNA Nucleotidylexotransferase | 1 | 1998 | 11 | 0.010 |
Why?
| Binding Sites | 1 | 2002 | 1224 | 0.010 |
Why?
| Constriction | 1 | 1998 | 46 | 0.010 |
Why?
| DNA Ligases | 1 | 1998 | 15 | 0.010 |
Why?
| Nucleic Acid Hybridization | 2 | 1989 | 193 | 0.010 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 175 | 0.010 |
Why?
| Estrogens | 2 | 1992 | 329 | 0.010 |
Why?
| Aorta, Abdominal | 1 | 1998 | 40 | 0.010 |
Why?
| Carbohydrates | 1 | 1977 | 59 | 0.010 |
Why?
| Erythrocyte Membrane | 1 | 1977 | 52 | 0.010 |
Why?
| Protein Kinase C-alpha | 1 | 1997 | 43 | 0.010 |
Why?
| Protein Kinase C-delta | 1 | 1997 | 69 | 0.010 |
Why?
| beta-Thromboglobulin | 2 | 1986 | 3 | 0.010 |
Why?
| Thromboxane B2 | 2 | 1986 | 27 | 0.010 |
Why?
| Magnetic Resonance Imaging | 1 | 2007 | 3175 | 0.010 |
Why?
| Young Adult | 1 | 2011 | 10799 | 0.010 |
Why?
| Running | 2 | 1988 | 227 | 0.010 |
Why?
| RNA, Transfer, Leu | 1 | 1994 | 7 | 0.010 |
Why?
| Pregnancy | 1 | 1987 | 5694 | 0.010 |
Why?
| Nuclear Proteins | 1 | 1999 | 597 | 0.010 |
Why?
| Melanoma | 1 | 1981 | 664 | 0.010 |
Why?
| Immune Adherence Reaction | 1 | 1974 | 2 | 0.010 |
Why?
| Atrophy | 1 | 1994 | 164 | 0.010 |
Why?
| Intercellular Junctions | 1 | 1994 | 34 | 0.010 |
Why?
| Neuraminidase | 1 | 1974 | 24 | 0.010 |
Why?
| Vibrio cholerae | 1 | 1974 | 8 | 0.010 |
Why?
| Leucine | 1 | 1994 | 117 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 1997 | 1012 | 0.010 |
Why?
| Genes, Reporter | 1 | 1994 | 270 | 0.010 |
Why?
| Tissue Distribution | 1 | 1994 | 334 | 0.010 |
Why?
| Skin Neoplasms | 1 | 1981 | 762 | 0.010 |
Why?
| Recombination, Genetic | 1 | 1994 | 173 | 0.010 |
Why?
| Chick Embryo | 1 | 1993 | 129 | 0.010 |
Why?
| Immune System | 1 | 1994 | 181 | 0.010 |
Why?
| Adolescent | 1 | 2011 | 18483 | 0.010 |
Why?
| Genetic Vectors | 1 | 1993 | 302 | 0.010 |
Why?
| DNA, Bacterial | 1 | 1993 | 314 | 0.010 |
Why?
| Denervation | 1 | 1992 | 21 | 0.010 |
Why?
| Oxygen | 1 | 1997 | 857 | 0.010 |
Why?
| Sheep | 1 | 1974 | 764 | 0.010 |
Why?
| Triiodothyronine | 1 | 1991 | 43 | 0.010 |
Why?
| Temperature | 1 | 1974 | 622 | 0.010 |
Why?
| Hypothyroidism | 1 | 1991 | 68 | 0.010 |
Why?
| Models, Cardiovascular | 1 | 1992 | 180 | 0.010 |
Why?
| Heart Valve Diseases | 1 | 1992 | 136 | 0.010 |
Why?
| Injections | 1 | 1991 | 167 | 0.010 |
Why?
| Orchiectomy | 1 | 1990 | 57 | 0.010 |
Why?
| Plasmids | 1 | 1991 | 355 | 0.010 |
Why?
| Ovariectomy | 1 | 1990 | 124 | 0.010 |
Why?
| Hematocrit | 1 | 1990 | 91 | 0.010 |
Why?
| DNA Probes | 1 | 1989 | 60 | 0.010 |
Why?
| Histocytochemistry | 1 | 1989 | 82 | 0.010 |
Why?
| Chickens | 1 | 1989 | 185 | 0.010 |
Why?
| Lactates | 1 | 1988 | 87 | 0.010 |
Why?
| Child | 1 | 1986 | 19137 | 0.000 |
Why?
| Testosterone | 1 | 1990 | 351 | 0.000 |
Why?
| Lactic Acid | 1 | 1988 | 282 | 0.000 |
Why?
| 6-Ketoprostaglandin F1 alpha | 1 | 1986 | 21 | 0.000 |
Why?
| Kidney | 1 | 1993 | 1357 | 0.000 |
Why?
| Lymphatic Metastasis | 1 | 1981 | 307 | 0.000 |
Why?
| Hemagglutination | 1 | 1977 | 7 | 0.000 |
Why?
| Mitogens | 1 | 1977 | 57 | 0.000 |
Why?
| Antibody Formation | 1 | 1977 | 276 | 0.000 |
Why?
| Lymphocytes | 1 | 1977 | 347 | 0.000 |
Why?
|
|
Buttrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|